SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001174947-15-000882
Filing Date
2015-05-19
Accepted
2015-05-19 07:00:30
Documents
4
Effectiveness Date
2015-05-19

Document Format Files

Seq Description Document Type Size
1 DEFA14A v411119_defa14a.htm DEFA14A 28419
2 GRAPHIC image_001.jpg GRAPHIC 3067
3 GRAPHIC image_003.jpg GRAPHIC 3004
4 GRAPHIC image_004.jpg GRAPHIC 2141
  Complete submission text file 0001174947-15-000882.txt   41464
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14895 | Film No.: 15875017
SIC: 2834 Pharmaceutical Preparations